Interventionelle Kardiologie - Universitätsspital Basel
Interventionelle Kardiologie - Universitätsspital Basel
Interventionelle Kardiologie - Universitätsspital Basel
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
08<br />
8.1 <br />
Finanzielles<br />
Andere Quellen<br />
• Actelion Schweiz: CAUSE-Pilot-Studie: Causes of dyspnea in primary care (T. Dieterle)<br />
• Abbott:<br />
Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
BASEL IV - Detection of myocardial ischemia (Ch. Müller)<br />
BASEL V - Acute Dyspnea (Ch. Müller)<br />
• Bayer AG: BEAT - AF (D. Conen, M. Kühne)<br />
• B. Braun Melsungen AG: BASKET-SMALL 2-Studie (R. Jeger)<br />
• BRAHMS:<br />
Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
BASEL IX - <strong>Basel</strong> Syncope Evaluation Study (Ch. Müller)<br />
BASEL VII - Acute Abdominal Pain (Ch. Müller)<br />
BASEL V - Acute Dyspnea (Ch. Müller)<br />
• Boehringer Ingelheim: BEAT-AF (D. Conen, M. Kühne)<br />
• Bühlmann: Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
• Critical Diagnostics: BASEL V - Acute Dyspnea (Ch. Müller)<br />
• Daiichi-Sankyo: BEAT - AF (D. Conen, M. Kühne)<br />
• 8sense: Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
• Hanela Foundation: GAPP - AF (D. Conen)<br />
• Hoffmann – La Roche Stiftung: BEAT-STEMI Pilot Studie (O. Pfister)<br />
• Mach Gaensslen Foundation: Gene expression patterns for the prediction of atrial fibrillation (D. Conen)<br />
• Merck Sharp & Dohme: BEAT-AF (D. Conen, M. Kühne)<br />
• Nanosphere: Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
• Novartis Schweiz: AVERT-Studie (Th. Dieterle)<br />
• Novartis Switzerland: GAPP - AF (D. Conen)<br />
• Polyphor Schweiz: Cardiac safety of novel peptide antibiotics (Th. Dieterle)<br />
• Pronota: BASEL V - Acute Dyspnea (Ch. Müller)<br />
• Roche:<br />
Advantageous predictors of acute coronary syndromes evaluation (APACE), (Ch. Müller)<br />
BASEL VII - Acute Abdominal Pain (Ch. Müller)<br />
• Sanofi Aventis: BEAT-AF (D. Conen, M. Kühne)<br />
• Swiss Life-Jubiläumsstiftung:<br />
Role of reactive oxygen species in the regulation of beta1-integrin expression and function in cardiomyocytes<br />
(G. Kuster Pfister)<br />
Contrast advanced ultrasound molecular imaging of vascular inflammation (B. Kaufmann)<br />
• Swiss Society of Hypertension: GAPP - AF (D. Conen)<br />
Gönner und Sponsoren<br />
• Abbott AG<br />
• Actelion Schweiz<br />
• A. Menarini AG<br />
• AstraZeneca<br />
• Bayer (Schweiz) AG<br />
• Biosense Webster<br />
• Biotronik Schweiz AG<br />
• Boehringer Ingelheim<br />
• Boston Scientific<br />
• B.R.A.H.M.S. GmbH<br />
• B. Braun Melsungen AG<br />
• Bühlmann Laborator AG<br />
• Daiichi Sankyo (Schweiz) AG<br />
• 8sens biognostics GmbH<br />
• Edwards Life Science AG<br />
• Eli Lilly (Suisse) SA<br />
• Förderverein <strong>Kardiologie</strong> <strong>Basel</strong><br />
• GlaxcoSmithKline AG<br />
• Grünenthal Pharma AG<br />
• Guidant Europe SA<br />
• IBSA<br />
• J.C. General Serv. CVBA<br />
• Medtronic (Schweiz) AG<br />
• Merck Sharp Dohme Chibret<br />
• Mundipharma Medical Company<br />
• Novartis AG<br />
• Nycomed Pharma AG<br />
• Pfizer AG<br />
• Robapharm AG<br />
• Roche<br />
• Sandoz Pharmaceuticals AG<br />
• Sanofi Aventis SA<br />
• Schwabe Pharma AG<br />
• Sigma-Tau Pharma AG<br />
• St. Jude Medical (Schweiz) AG<br />
• Stiftung Kardiovaskuläre Forschung <strong>Basel</strong><br />
• Swiss Life AG<br />
• Takeda Pharma AG<br />
• Vifor Pharma<br />
• Viollier AG<br />
61<br />
8.2
Change language